NCT03046953
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University College London Hospital London, United Kingdom
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,107 public trials
2,039 recruiting studies
Lymphoproliferative Disorders trial results
NCT04315337
- Conditions
- Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +34 more
- Locations
-
- Temple University Philadelphia, Pennsylvania, United States
NCT04313582
- Conditions
- Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +34 more
- Locations
-
- Temple University Philadelphia, Pennsylvania, United States
NCT00557193
- Conditions
- Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia, +12 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT03942263
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
- Locations
-
- State budgetary healthcare institution of the Astrakhan region Alexander-Mariinsky regional clinical hospital Astrakhan, Russia
- Autonomous Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of Chuvashia Cheboksary, Russia
- State budgetary health care institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine" Chelyabinsk, Russia
- State Budget Public Health Institution "Regional Oncological Dispensary" Irkutsk, Russia
Completed
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
NCT02654990
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Novartis Investigative Site Fayetteville, Arkansas, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Fort Collins, Colorado, United States
- Novartis Investigative Site Gainesville, Florida, United States
NCT03346096
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Chaim Sheba Medical Center Ramat Gan, Israel
NCT04555811
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
- Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States
NCT02646098
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Department for Medical Oncology; University Hospital/Inselspital Bern, Switzerland
NCT04659798
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- H. Puerta del Mar Cadiz, Andalusia, Spain
- Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
- H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
- H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain